This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Anafranil (Clomipramine) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (60)
Death (1)
Life Threatening Events (7)
Reports by Reaction Type
Cytolytic Hepatitis (12),
Sopor (10),
Cholestasis (9),
Liver Injury (8),
Jaundice (7),
Hepatic Failure (7),
Condition Aggravated (7),
Hepatic Cirrhosis (6),
Alcoholic Liver Disease (6),
Ascites (6),
Suicide Attempt (6),
Urticaria (5)
Below are a few examples of reports where side effects / adverse reactions may be related to Anafranil (Clomipramine). For a complete list or a specific selection of reports, please use the links above.
Possible Anafranil side effects in 73 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-24
Patient: 73 year old female
Reactions: Dermo-Hypodermitis, Fungal Oesophagitis, Shock Haemorrhagic, Cytolytic Hepatitis, Cholestasis, Necrotising Fasciitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aldactone
Dosage: 50 mg, 1x/day
Administration route: Oral
End date: 2012-06-26
Anafranil
Dosage: 75 mg, 1x/day
Administration route: Oral
Indication: Depression
Start date: 2012-05-01
End date: 2012-06-26
Levofloxacin
Dosage: 500 mg, 2x/day
Administration route: Oral
Start date: 2012-05-25
End date: 2012-06-26
Orbenin CAP
Dosage: 3 g, 3x/day
Start date: 2012-05-25
End date: 2012-06-26
Other drugs received by patient: Humalog; Lyrica; Lasix; Oxycodone Hydrochloride; Ketoprofen; Penicillin G Sodium; Clindamycin HCL; Nexium; Prednisone TAB; Oxycontin; Glucophage
Possible Anafranil side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-24
Patient: male
Reactions: Dysarthria, Tachycardia, Snoring, Drug Abuse, Sopor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Anafranil
Indication: Drug Abuse
Start date: 2012-07-13
End date: 2012-07-13
Clonazepam
Indication: Drug Abuse
Start date: 2012-07-13
End date: 2012-07-13
Haldol
Indication: Drug Abuse
Start date: 2012-07-13
End date: 2012-07-13
Lantanon
Indication: Drug Abuse
Start date: 2012-07-13
End date: 2012-07-13
Olanzapine
Indication: Drug Abuse
Start date: 2012-07-13
End date: 2012-07-13
Trazodone HCL
Indication: Drug Abuse
Start date: 2012-07-13
End date: 2012-07-13
Valproic Acid
Indication: Drug Abuse
Start date: 2012-07-13
End date: 2012-07-13
Possible Anafranil side effects in male
Reported by a physician from Italy on 2012-08-22
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Hypotension, Multiple Drug Overdose, Self Injurious Behaviour, Sopor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Anafranil
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-07-13
End date: 2012-07-13
Clonazepam
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-07-13
End date: 2012-07-13
Haloperidol Lactate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-13
End date: 2012-07-13
Lantanon
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-07-13
End date: 2012-07-13
Olanzapine
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-07-13
End date: 2012-07-13
Trazodone HCL
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-07-13
End date: 2012-07-13
Valproate Sodium
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-07-13
End date: 2012-07-13
Possible Anafranil side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-21
Patient: 65 year old female
Reactions: Urticaria, Hepatocellular Injury, Cholestasis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Anafranil
Dosage: 150 mg, 1x/day
Administration route: Oral
Indication: Major Depression
Start date: 2012-06-22
Avastin
Dosage: unk
Indication: Breast Cancer
Start date: 2012-02-01
End date: 2012-07-16
Chlorpromazine HCL
Dosage: 200 drop(s)
Administration route: Oral
Indication: Major Depression
Start date: 2012-06-20
End date: 2012-06-28
Midodrine Hydrochloride
Dosage: unk
Administration route: Oral
Indication: Orthostatic Hypotension
Start date: 2012-06-22
End date: 2012-07-16
Paclitaxel
Dosage: unk
Indication: Breast Cancer Recurrent
Start date: 2012-02-01
End date: 2012-07-16
Zofran
Dosage: 8 mg, weekly
Administration route: Oral
Indication: Vomiting
Start date: 2012-02-01
End date: 2012-07-16
Zyprexa
Dosage: 10 mg, 1x/day
Administration route: Oral
Indication: Major Depression
Start date: 2012-06-28
End date: 2012-07-16
Other drugs received by patient: Nexium
Possible Anafranil side effects in male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-20
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Hyponatraemia, Brain Oedema, Serotonin Syndrome
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Anafranil
Dosage: 75 mg
Administration route: Oral
Indication: Depression
Start date: 2012-07-10
End date: 2012-07-17
Escitalopram
Dosage: 20 mg
Administration route: Oral
Indication: Depression
Start date: 2012-07-10
End date: 2012-07-17
Other drugs received by patient: Lorazepam; Noctamide; Pravastatin
Possible Anafranil side effects in female
Reported by a consumer/non-health professional from France on 2012-08-16
Patient: female
Reactions: Cytolytic Hepatitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Anafranil
Dosage: 150 mg, unknown
Administration route: Oral
Indication: Major Depression
Start date: 2012-06-22
End date: 2012-07-04
Anafranil
Dosage: 75 mg, unknown
Administration route: Oral
Start date: 2012-07-05
Anafranil
Dosage: unk unk, unknown
Start date: 2012-06-20
End date: 2012-06-21
Avastin
Dosage: 25 mg/ml, 1x/week
Indication: Breast Cancer Recurrent
Start date: 2012-02-01
End date: 2012-07-16
Largactil / 00011902 /
Dosage: 150 - 250 df 4% drops, unknown
Administration route: Oral
Indication: Major Depression
Start date: 2012-06-20
End date: 2012-06-28
Midodrine Hydrochloride
Dosage: 15 mg (6 tablets), unknown
Administration route: Oral
Indication: Orthostatic Hypotension
Start date: 2012-06-22
End date: 2012-07-02
Midodrine Hydrochloride
Dosage: 30 mg (12 tablets), unknown
Administration route: Oral
Start date: 2012-07-03
End date: 2012-07-16
Ondansetron
Dosage: 1 df, 1x/week
Administration route: Oral
Indication: Procedural Vomiting
Start date: 2012-02-01
End date: 2012-07-16
Taxol
Dosage: 1 df, 1x/week
Indication: Breast Cancer Recurrent
Start date: 2012-02-01
End date: 2012-07-16
Zyprexa
Dosage: 10 mg, unknown
Administration route: Oral
Indication: Major Depression
Start date: 2012-06-28
End date: 2012-07-16
Other drugs received by patient: Corticosteroid NOS; Esomeprazole
Possible Anafranil side effects in male
Reported by a physician from Italy on 2012-08-16
Patient: male
Reactions: Drug Abuse, Sopor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Anafranil
Administration route: Oral
Indication: Drug Abuse
Start date: 2012-07-13
End date: 2012-07-13
Clonazepam
Administration route: Oral
Indication: Drug Abuse
Start date: 2012-07-13
End date: 2012-07-13
Haldol
Administration route: Oral
Indication: Drug Abuse
Start date: 2012-07-13
End date: 2012-07-13
Lantanon
Administration route: Oral
Indication: Drug Abuse
Start date: 2012-07-13
End date: 2012-07-13
Olanzapine
Administration route: Oral
Indication: Drug Abuse
Start date: 2012-07-13
End date: 2012-07-13
Trazodone HCL
Administration route: Oral
Indication: Drug Abuse
Start date: 2012-07-13
End date: 2012-07-13
Valproate Sodium
Administration route: Oral
Indication: Drug Abuse
Start date: 2012-07-13
End date: 2012-07-13
Possible Anafranil side effects in male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-09
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Brain Oedema, Hyponatraemia, Serotonin Syndrome
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Anafranil
Dosage: 75 mg
Administration route: Oral
Indication: Depression
Start date: 2012-07-10
End date: 2012-07-17
Escitalopram
Dosage: 20 mg
Administration route: Oral
Indication: Depression
Start date: 2012-07-10
End date: 2012-07-17
Other drugs received by patient: Noctamide; Lorazepam; Pravastatin
Possible Anafranil side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-08
Patient: 65 year old female
Reactions: Hepatocellular Injury, Urticaria, Cholestasis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Anafranil
Dosage: 150 mg, 1x/day
Administration route: Oral
Indication: Major Depression
Start date: 2012-06-22
Avastin
Dosage: unk
Indication: Breast Cancer
Start date: 2012-02-01
End date: 2012-07-16
Chlorpromazine HCL
Dosage: 200 drop(s)
Administration route: Oral
Indication: Major Depression
Start date: 2012-06-20
End date: 2012-06-28
Midodrine Hydrochloride
Dosage: unk
Administration route: Oral
Indication: Orthostatic Hypotension
Start date: 2012-06-22
End date: 2012-07-16
Paclitaxel
Dosage: unk
Indication: Breast Cancer Recurrent
Start date: 2012-02-01
End date: 2012-07-16
Zofran
Dosage: unk
Administration route: Oral
Indication: Vomiting
Start date: 2012-02-01
End date: 2012-07-16
Zyprexa
Dosage: 10 mg, unk
Administration route: Oral
Indication: Major Depression
Start date: 2012-06-28
End date: 2012-07-16
Other drugs received by patient: Esomeprazole
Possible Anafranil side effects in 65 year old female
Reported by a physician from France on 2012-08-02
Patient: 65 year old female
Reactions: Cytolytic Hepatitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Anafranil
Start date: 2012-07-05
Anafranil
Dosage: 25 mg/ 2 ml
Indication: Major Depression
Start date: 2012-06-20
Anafranil
Administration route: Oral
Start date: 2012-06-22
Avastin
Indication: Breast Cancer
End date: 2012-07-16
Chlorpromazine HCL
Indication: Major Depression
Start date: 2012-06-20
End date: 2012-06-28
Midodrine Hydrochloride
End date: 2012-07-16
Midodrine Hydrochloride
Administration route: Oral
Indication: Orthostatic Hypotension
Start date: 2012-06-22
Taxol
Indication: Breast Cancer Recurrent
End date: 2012-07-16
Zofran
Administration route: Oral
Indication: Vomiting
End date: 2012-07-16
Zyprexa
Administration route: Oral
Indication: Major Depression
Start date: 2012-06-28
End date: 2012-07-16
Possible Anafranil side effects in female
Reported by a physician from France on 2012-08-02
Patient: female
Reactions: Urticaria, Hepatocellular Injury, Cholestasis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Anafranil
Dosage: 150mg per day
Administration route: Oral
Indication: Major Depression
Start date: 2012-06-22
Avastin
Dosage: 25mgml weekly
Indication: Breast Cancer
Start date: 2012-02-01
End date: 2012-07-16
Chlorpromazine HCL
Dosage: 200drop per day
Administration route: Oral
Indication: Major Depression
Start date: 2012-06-20
End date: 2012-06-28
Midodrine Hydrochloride
Administration route: Oral
Indication: Orthostatic Hypotension
Start date: 2012-06-22
End date: 2012-07-16
Taxol
Indication: Breast Cancer Recurrent
Start date: 2012-02-01
End date: 2012-07-16
Zofran
Dosage: 8mg weekly
Administration route: Oral
Indication: Vomiting
Start date: 2012-02-01
End date: 2012-07-16
Zyprexa
Dosage: 10mg per day
Administration route: Oral
Indication: Major Depression
Start date: 2012-06-28
End date: 2012-07-16
Other drugs received by patient: Nexium; Corticoid
Possible Anafranil side effects in female
Reported by a consumer/non-health professional from Denmark on 2012-08-01
Patient: female
Reactions: Cytolytic Hepatitis
Drug(s) suspected as cause:
Anafranil
Dosage: 150 mg, unknown
Indication: Major Depression
Start date: 2012-06-22
End date: 2012-07-04
Anafranil
Dosage: 75 mg, unknown
Administration route: Oral
Start date: 2012-07-05
Avastin
Dosage: 1 df, 1x/week
Indication: Breast Cancer
Start date: 2012-02-01
End date: 2012-07-16
Largactil / 00011901 /
Dosage: 250 df, unknown (150-250 df 4% drops for oral use)
Administration route: Oral
Indication: Major Depression
Start date: 2012-06-20
End date: 2012-06-28
Midodrine Hydrochloride
Dosage: 30 mg, unknown
Administration route: Oral
Start date: 2012-07-03
End date: 2012-07-16
Midodrine Hydrochloride
Dosage: 15 mg, unknown
Administration route: Oral
Indication: Orthostatic Hypotension
Start date: 2012-06-22
End date: 2012-07-02
Ondansetron
Dosage: 1 df, 1x/week
Indication: Procedural Vomiting
Start date: 2012-02-01
End date: 2012-07-16
Taxol
Dosage: 1 df, 1x/week
Indication: Breast Cancer
Start date: 2012-02-01
End date: 2012-07-16
Zyprexa
Dosage: 10 mg, unknown
Administration route: Oral
Indication: Major Depression
Start date: 2012-06-28
End date: 2012-07-16
Other drugs received by patient: Esomeprazole; Corticosteroid NOS
Possible Anafranil side effects in 73 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-27
Patient: 73 year old female
Reactions: Dermo-Hypodermitis, Cytolytic Hepatitis, Cholestasis, Necrotising Fasciitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aldactone
Dosage: 50 mg, 1x/day
Administration route: Oral
End date: 2012-06-26
Anafranil
Dosage: 75 mg, 1x/day
Administration route: Oral
Indication: Depression
Start date: 2012-05-01
End date: 2012-06-26
Levofloxacin
Dosage: 500 mg, 2x/day
Administration route: Oral
Start date: 2012-05-25
End date: 2012-06-26
Orbenin CAP
Dosage: 3 g, 3x/day
Start date: 2012-05-25
End date: 2012-06-26
Other drugs received by patient: Humalog; Ketoprofen; Oxycodone HCL; Penicillin G Sodium; Nexium; Lyrica; Clindamycin HCL; Glucophage; Prednisone TAB; Oxycontin; Lasix
Possible Anafranil side effects in 73 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-25
Patient: 73 year old female
Reactions: Cytolytic Hepatitis, Cholestasis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aldactone
Dosage: 50 mg, 1x/day
Administration route: Oral
End date: 2012-06-26
Anafranil
Dosage: 75 mg, 1x/day
Administration route: Oral
Indication: Depression
Start date: 2012-05-01
End date: 2012-06-26
Levofloxacin
Dosage: 500 mg, 2x/day
Administration route: Oral
Start date: 2012-05-25
End date: 2012-06-26
Orbenin CAP
Dosage: 3 g, 3x/day
Start date: 2012-05-25
End date: 2012-06-26
Other drugs received by patient: Lasix; Nexium; Clindamycin HCL; Oxycodone HCL; Prednisone TAB; Humalog; Lyrica; Ketoprofen; Penicillin G Sodium; Oxycontin; Glucophage
Possible Anafranil side effects in 38 year old male
Reported by a physician from Italy on 2012-07-23
Patient: 38 year old male, weighing 80.0 kg (176.0 pounds)
Reactions: Hypotension, Multiple Drug Overdose, Self Injurious Behaviour, Sopor
Drug(s) suspected as cause:
Anafranil
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-07-13
End date: 2012-07-13
Clonazepam
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-07-13
End date: 2012-07-13
Haldol
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-13
End date: 2012-07-13
Lantanon
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-07-13
End date: 2012-07-13
Olanzapine
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-07-13
End date: 2012-07-13
Trazodone HCL
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-07-13
End date: 2012-07-13
Valproate Sodium
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-07-13
End date: 2012-07-13
Possible Anafranil side effects in female
Reported by a physician from France on 2012-07-18
Patient: female
Reactions: Agitation, Confusional State, Hyponatraemia, Urinary Retention
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Anafranil
Administration route: Oral
Start date: 2011-03-25
Atorvastatin
Administration route: Oral
Start date: 2010-12-15
Imovane
Administration route: Oral
Start date: 2011-11-24
Oxazepam
Administration route: Oral
Start date: 2011-01-28
Quetiapine Fumarate
Administration route: Oral
Start date: 2011-11-29
Possible Anafranil side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-18
Patient: 67 year old female
Reactions: Agitation, Confusional State, Hyponatraemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Anafranil
Dosage: 150 mg, 1x/day
Administration route: Oral
Start date: 2011-03-25
Atorvastatin
Dosage: 20 mg, 1x/day
Administration route: Oral
Start date: 2010-12-15
Imovane
Dosage: 7.5 mg, 1x/day
Administration route: Oral
Start date: 2011-11-24
Oxazepam
Dosage: 10 mg, 1x/day
Administration route: Oral
Start date: 2011-01-28
Quetiapine Fumarate
Dosage: 300 mg, 1x/day
Administration route: Oral
Start date: 2011-11-29
Possible Anafranil side effects in 24 year old male
Reported by a consumer/non-health professional from Brazil on 2012-07-04
Patient: 24 year old male, weighing 74.0 kg (162.8 pounds)
Reactions: Attention Deficit / Hyperactivity Disorder
Drug(s) suspected as cause:
Anafranil
Dosage: 3 df, qd
Indication: Anxiety
Trileptal
Dosage: 1 df, tid
Indication: Bipolar Disorder
Possible Anafranil side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-02
Patient: male
Reactions: Hyperkalaemia, Urinary Retention, Constipation, Faecaloma, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Anafranil
Dosage: 20 mg
Administration route: Oral
Indication: Depression
Spiriva
Dosage: one puff on morning
Indication: Chronic Obstructive Pulmonary Disease
Other drugs received by patient: Aminophylline; Alfuzosin HCL; Forlax; Aspirin
Possible Anafranil side effects in male
Reported by a physician from Germany on 2012-06-22
Patient: male
Reactions: Delirium
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Anafranil
Administration route: Oral
Start date: 2012-02-04
End date: 2012-02-07
Anafranil
Administration route: Oral
Start date: 2012-02-01
End date: 2012-02-01
Anafranil
Administration route: Oral
Start date: 2012-02-02
End date: 2012-02-03
Anafranil
Administration route: Oral
Start date: 2012-02-08
End date: 2012-02-21
Anafranil
Administration route: Oral
Start date: 2012-02-22
End date: 2012-02-24
Lithium Carbonate
Administration route: Oral
Start date: 2011-11-01
End date: 2012-02-20
Lithium Carbonate
Administration route: Oral
Start date: 2012-02-23
Mirtazapine
Administration route: Oral
Start date: 2011-11-01
End date: 2012-02-23
Seroquel XR
Administration route: Oral
Start date: 2012-02-02
End date: 2012-02-27
Seroquel XR
Administration route: Oral
Start date: 2011-11-01
End date: 2012-02-01
Seroquel XR
Administration route: Oral
Start date: 2012-02-28
Other drugs received by patient: Clonazepam; Clonazepam; Allopurinol; Clonazepam
Possible Anafranil side effects in female
Reported by a consumer/non-health professional from Brazil on 2012-06-21
Patient: female
Reactions: Drug Dependence
Drug(s) suspected as cause:
Anafranil
Dosage: 1 df, qd
Formoterol Fumarate
Dosage: 1 df, bid
Naphazoline Hydrochloride
Dosage: 1 df, qd
Slow-K
Dosage: 1 df, qid
Possible Anafranil side effects in male
Reported by a consumer/non-health professional from United States on 2012-06-21
Patient: male, weighing 80.3 kg (176.6 pounds)
Reactions: Psychotic Disorder, Drug Interaction
Drug(s) suspected as cause:
Anafranil
Dosage: 1 tablet daily oral
Administration route: Oral
Indication: Obsessive-Compulsive Disorder
Start date: 1990-01-01
End date: 1991-01-01
Prozac
Dosage: 1 tablet daily oral
Administration route: Oral
Indication: Obsessive-Compulsive Disorder
Start date: 1989-01-01
Prozac
Dosage: 1 tablet daily oral
Administration route: Oral
Indication: Obsessive-Compulsive Disorder
Start date: 1991-01-01
Other drugs received by patient: Chlorpromazine HCL
Possible Anafranil side effects in male
Reported by a physician from Japan on 2012-06-14
Patient: male, weighing 78.0 kg (171.6 pounds)
Reactions: Road Traffic Accident, Contusion, Somnolence, Erythema, Haemorrhage Subcutaneous
Drug(s) suspected as cause:
Anafranil
Administration route: Oral
Indication: Depression
Start date: 2011-04-14
End date: 2011-07-14
Anafranil
Administration route: Oral
Indication: Pain
Start date: 2011-04-14
End date: 2011-07-14
Anafranil
Administration route: Oral
Indication: Fibromyalgia
Start date: 2011-04-14
End date: 2011-07-14
Anafranil
Administration route: Oral
Indication: Sleep Disorder Therapy
Start date: 2011-04-14
End date: 2011-07-14
Codeine Phosphate
Administration route: Oral
Start date: 2009-09-28
Codeine Phosphate
Administration route: Oral
Start date: 2011-02-22
Codeine Phosphate
Administration route: Oral
Start date: 2010-08-20
Codeine Phosphate
Administration route: Oral
Indication: Pain
Start date: 2010-10-05
Codeine Phosphate
Administration route: Oral
Start date: 2011-04-19
End date: 2011-06-13
Codeine Phosphate
Administration route: Oral
Start date: 2009-12-01
Depas
Administration route: Oral
Indication: Fibromyalgia
Depas
Administration route: Oral
Indication: Sleep Disorder Therapy
Depas
Administration route: Oral
Indication: Depression
Depas
Administration route: Oral
Indication: Pain
Fentanyl-100
Indication: Pain
Start date: 2011-06-14
End date: 2011-07-20
Paxil
Administration route: Oral
Indication: Pain
Paxil
Administration route: Oral
Indication: Sleep Disorder Therapy
Paxil
Administration route: Oral
Indication: Fibromyalgia
Paxil
Administration route: Oral
Indication: Depression
Silece
Administration route: Oral
Indication: Fibromyalgia
Silece
Administration route: Oral
Indication: Pain
Silece
Administration route: Oral
Indication: Sleep Disorder Therapy
Silece
Administration route: Oral
Indication: Depression
Tetramide
Administration route: Oral
Indication: Sleep Disorder Therapy
Start date: 2011-07-04
Tetramide
Administration route: Oral
Indication: Pain
Start date: 2011-07-04
Tetramide
Administration route: Oral
Indication: Depression
Start date: 2011-07-04
Tetramide
Administration route: Oral
Indication: Fibromyalgia
Start date: 2011-07-04
Other drugs received by patient: Omeprazole; Celebrex; Mexitil; Bisoprolol Fumarate; Primperan TAB
Possible Anafranil side effects in male
Reported by a physician from Japan on 2012-06-05
Patient: male, weighing 78.0 kg (171.6 pounds)
Reactions: Road Traffic Accident, Contusion, Drug Intolerance, Somnolence
Drug(s) suspected as cause:
Anafranil
Administration route: Oral
Indication: Pain
Start date: 2011-04-14
End date: 2011-07-14
Codeine Phosphate
Administration route: Oral
Start date: 2011-07-05
End date: 2011-07-11
Codeine Phosphate
Administration route: Oral
Start date: 2009-09-01
Codeine Phosphate
Administration route: Oral
Indication: Pain
Start date: 2011-06-21
End date: 2011-06-27
Codeine Phosphate
Administration route: Oral
Start date: 2011-06-28
End date: 2011-07-04
Codeine Phosphate
Administration route: Oral
Start date: 2011-06-14
End date: 2011-06-20
Depas
Administration route: Oral
Indication: Pain
Fentanyl-100
Indication: Pain
Start date: 2011-06-14
End date: 2011-07-20
Paxil
Administration route: Oral
Indication: Pain
Silece
Administration route: Oral
Indication: Pain
Tetramide
Administration route: Oral
Indication: Pain
Start date: 2011-07-04
Other drugs received by patient: Omeprazole; Primperan TAB; Bisoprolol Fumarate; Mexitil; Celebrex
Possible Anafranil side effects in 76 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-15
Patient: 76 year old female, weighing 60.5 kg (133.1 pounds)
Reactions: Orthostatic Hypotension, Fall
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Anafranil
Administration route: Oral
End date: 2011-04-26
Lasix
Administration route: Oral
End date: 2011-04-24
Possible Anafranil side effects in male
Reported by a physician from Japan on 2012-05-04
Patient: male, weighing 78.0 kg (171.6 pounds)
Reactions: Contusion, Road Traffic Accident, Drug Intolerance, Somnolence
Drug(s) suspected as cause:
Anafranil
Administration route: Oral
Indication: Pain
Start date: 2011-04-14
End date: 2011-07-14
Codeine Phosphate
Administration route: Oral
Start date: 2011-07-05
End date: 2011-07-11
Codeine Phosphate
Administration route: Oral
Start date: 2011-06-28
End date: 2011-07-04
Codeine Phosphate
Administration route: Oral
Start date: 2009-09-01
Codeine Phosphate
Administration route: Oral
Start date: 2011-06-14
End date: 2011-06-20
Codeine Phosphate
Administration route: Oral
Indication: Pain
Start date: 2011-06-21
End date: 2011-06-27
Depas
Administration route: Oral
Indication: Pain
Fentanyl-100
Indication: Pain
Start date: 2011-06-14
End date: 2011-07-20
Paxil
Administration route: Oral
Indication: Pain
Silece
Administration route: Oral
Indication: Pain
Tetramide
Administration route: Oral
Indication: Pain
Start date: 2011-07-04
Other drugs received by patient: Bisoprolol Fumarate; Omeprazole; Primperan TAB; Celebrex; Mexitil
Possible Anafranil side effects in 52 year old male
Reported by a consumer/non-health professional from Italy on 2012-04-18
Patient: 52 year old male
Reactions: Jaundice, Liver Injury, Cytolytic Hepatitis, Blood Albumin Decreased, Hepatic Failure, Condition Aggravated, Alcoholic Liver Disease, Ascites, Hepatosplenomegaly, Hepatic Cirrhosis, Prothrombin Level Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alprazolam
Dosage: 0.25 mg, tid
Administration route: Oral
Indication: Mental Disorder
End date: 2012-01-21
Anafranil
Dosage: 0.25 mg, tid
Administration route: Oral
Indication: Depression
Start date: 2012-01-01
End date: 2012-01-21
Escitalopram
Dosage: 20 mg, daily
Administration route: Oral
Indication: Depression
Start date: 2011-10-01
End date: 2012-01-01
Rasilez HCT
Dosage: 1 df, daily
Administration route: Oral
Indication: Hypertension
End date: 2012-01-21
Zyprexa
Dosage: 5 mg, daily
Administration route: Oral
Indication: Depression
Start date: 2011-11-23
End date: 2012-01-05
Other drugs received by patient: Prazepam
Possible Anafranil side effects in 52 year old male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-04-18
Patient: 52 year old male
Reactions: Jaundice, Liver Injury, Cytolytic Hepatitis, Condition Aggravated, Blood Albumin Decreased, Hepatic Failure, Alcoholic Liver Disease, Ascites, Hepatosplenomegaly, Hepatic Cirrhosis, Prothrombin Level Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alprazolam
Dosage: 0.25 mg, tid
Administration route: Oral
Indication: Mental Disorder
End date: 2012-01-21
Anafranil
Dosage: 0.25 mg, tid
Administration route: Oral
Indication: Depression
Start date: 2012-01-01
End date: 2012-01-21
Escitalopram
Dosage: 20 mg, daily
Administration route: Oral
Indication: Depression
Start date: 2011-10-01
End date: 2012-01-01
Rasilez HCT
Dosage: 1 df, daily
Administration route: Oral
Indication: Hypertension
End date: 2012-01-21
Zyprexa
Dosage: 5 mg, daily
Administration route: Oral
Indication: Depression
Start date: 2011-11-23
End date: 2012-01-05
Other drugs received by patient: Prazepam
Possible Anafranil side effects in 52 year old male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-04-12
Patient: 52 year old male
Reactions: Liver Injury, Jaundice, Cytolytic Hepatitis, Condition Aggravated, Blood Albumin Decreased, Hepatic Failure, Alcoholic Liver Disease, Ascites, Prothrombin Level Decreased, Hepatic Cirrhosis, Hepatosplenomegaly
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alprazolam
Dosage: 0.25 mg, tid
Administration route: Oral
Indication: Mental Disorder
End date: 2012-01-21
Anafranil
Dosage: 0.25 mg, tid
Administration route: Oral
Indication: Depression
Start date: 2012-01-01
End date: 2012-01-21
Escitalopram
Dosage: 20 mg, daily
Administration route: Oral
Indication: Depression
Start date: 2011-10-01
End date: 2012-01-01
Rasilez HCT
Dosage: 1 df, daily
Administration route: Oral
Indication: Hypertension
End date: 2012-01-21
Zyprexa
Dosage: 5 mg, daily
Administration route: Oral
Indication: Depression
Start date: 2011-11-23
End date: 2012-01-05
Other drugs received by patient: Prazepam
Possible Anafranil side effects in 52 year old male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-04-12
Patient: 52 year old male
Reactions: Liver Injury, Jaundice, Cytolytic Hepatitis, Blood Albumin Decreased, Condition Aggravated, Hepatic Failure, Alcoholic Liver Disease, Ascites, Hepatosplenomegaly, Hepatic Cirrhosis, Prothrombin Level Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alprazolam
Dosage: 0.25 mg, tid
Administration route: Oral
Indication: Mental Disorder
End date: 2012-01-21
Anafranil
Dosage: 0.25 mg, tid
Administration route: Oral
Indication: Depression
Start date: 2012-01-01
End date: 2012-01-21
Escitalopram
Dosage: 20 mg, daily
Administration route: Oral
Indication: Depression
Start date: 2011-10-01
End date: 2012-01-01
Rasilez HCT
Dosage: 1 df, daily
Administration route: Oral
Indication: Hypertension
End date: 2012-01-21
Zyprexa
Dosage: 5 mg, daily
Administration route: Oral
Indication: Depression
Start date: 2011-11-23
End date: 2012-01-05
Other drugs received by patient: Prazepam
|